Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for ischemia-reperfusion injury in TKA
NCT03482544Phase 4Completed
- Sponsor
- Baskent University
- Start
- Oct 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in reperfusion injury (IRI), sponsored by Baskent University. Started Oct 2018; status: completed.
02
Drugs
pregabalin
03
Conditions
reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT03482544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482544.